Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)

v3.23.3
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Income Tax Disclosure [Abstract]    
Incurred loss $ 2,000  
Deferred Tax Assets:    
Net operating loss carryforwards 20,673,000 $ 20,654,000
Research & development credit carryforward 27,000 27,000
Capitalized research and development expenses 1,405,000
Stock compensation 971,000 1,636,000
Lease liability 736,000 802,000
Other, net 776,000 559,000
Gross deferred tax assets 24,588,000 23,678,000
Less Valuation allowance (23,923,000) (22,951,000)
Total deferred tax assets 665,000 727,000
Deferred Tax Liabilities:    
Right of use asset (665,000) (727,000)
Total deferred tax liabilities (665,000) (727,000)
Net deferred tax liabilities